ADVANCED PROTEOME THERAPEUTICS CORPORATION

Altre lingue Advanced Proteome Therapeutics Corporation

Azioni

APC.H

CA0076282098

Tempo differito Toronto S.E. Altri mercati azionari 21:55:53 04/12/2023			Variaz. 5gg	Var. 1 gen.
0,005 ^CAD	-.--%		-.--%	-.--%

2023	Advanced Proteome Therapeutics Corporation riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 aprile 2023	CI
2023	Advanced Proteome Therapeutics Corporation riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 31 gennaio 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Canadian Investment Regulatory Organization Trading Halt - APC.H	05/12
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30/06/23
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	29/03/23
IIROC Trading Resumption - APC	17/01/23
IIROC Trading Halt - APC	17/01/23
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	17/01/23
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	23/12/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	21/12/22
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	21/11/22
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	15/11/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	15/11/22
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	04/08/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	28/06/22
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	13/04/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	25/03/22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	17/12/21
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	29/11/21
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	29/11/21
Advanced Proteome Therapeutics Provides Update on COVID Program	24/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Advanced Proteome Therapeutics Corporation

Azioni

APC.H

CA0076282098

Altre lingue

Filtri